Novavax Reports Second Quarter 2009 Financi... (phone at 1 (866) 206-5917 (U.S. or Canad...)

Novavax Reports Second Quarter 2009 Financial Results

Date:8/7/2009

phone at 1 (866) 206-5917 (U.S. or Canada) or 1 (703) 639-1106 (International). An archive of the conference call will be available on Novavax's website approximately one hour after the event for 90 days. A replay of the webcast will be available on the website for 90 days after the call and a replay of the conference call will also be available by telephone beginning August 7th, 2009 at 1:00 pm through August 12, 2009 at 11:59pm. To access the replay, dial 1 (888) 266 2081 and enter pass code 1366728.

Forward Looking Statements

Statements herein relating to future financial or business performance, conditions or strategies and other financial and business matters, including expectations regarding revenues, operating expenses, cash burn, and clinical developments and anticipated milestones are forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Novavax cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include risks and uncertainties, including the Company's ability to progress any product candidates in preclinical or clinical trials; the scope, rate and progress of its preclinical studies and clinical trials and other research and development activities; clinical trial results; even if the data from preclinical studies or clinical trials is positive, the product may not prove to be safe and efficacious; Novavax's pilot plant facility is subject to extensive validation and FDA inspections, which may result in delays and increased costs; the success of the Company's foreign joint venture and licensing agreements; the Company's ability to enter into future collaborations with industry partners and the government and the terms, timing and success of any such collab
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9
Related biology technology :

1. Novavax Announces Appointment of Frederick W. Driscoll as Vice President, Chief Financial Officer and Treasurer
2. Novavax Announces Release Date of 2009 Second Quarter, Financial Results and Investor Conference Call
3. Novavax Announces Selection of a Respiratory Syncytial Virus Vaccine Candidate for Advanced Preclinical Studies
4. Novavax Announces Appointment of John J. Trizzino as Senior Vice President, International and Government Alliances
5. Novavax Announces Repayment of $5 Million of Convertible Debt
6. Cadila Pharmaceuticals Launches Joint Venture With Novavax in India
7. Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain
8. Novavax Appoints Stanley Erck to Board of Directors
9. Preclinical Proof-of-Concept Studies Published for Novavax Seasonal Influenza Virus-Like-Particle Vaccine
10. Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2009
11. Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus

Post Your Comments:

(Date:12/14/2009)... and THOUSAND OAKS, Calif., Dec. 14 ... Amgen Inc.(Nasdaq: AMGN ) today announced that ... worldwide rights to Array,s small-molecule glucokinase activator program, ... 1 clinical trial in patients with Type 2 ... the agreement, Array will receive an upfront payment ...

(Date:12/14/2009)... third edition of Infusion Nursing: An ... the Infusion Nurses Society (INS), includes Totect(®), the ... are a group of chemotherapy medications including daunorubicin, ... in the treatment of various types of cancer ... to the INS publication: "In September 2007, the ...

(Date:12/14/2009)... -- Decision Resources, one of the world,s leading ... issues, finds that, owing to the launches of ... will increase more than sevenfold from $790 million ... the United States, France, Germany, Italy, Spain, the ... report entitled Atrial Fibrillation finds that ...

(Date:12/11/2009)... Dendreon Corporation (Nasdaq: DNDN ) announced today ... offering have exercised in full their option to ... at the public offering price of $24.75 per ... the size of the offering to an aggregate ... expects to receive net proceeds from the offering ...

Breaking Biology Technology:Array BioPharma and Amgen Partner in Type 2 Diabetes 2 Array BioPharma and Amgen Partner in Type 2 Diabetes 3 Array BioPharma and Amgen Partner in Type 2 Diabetes 4 Array BioPharma and Amgen Partner in Type 2 Diabetes 5 Array BioPharma and Amgen Partner in Type 2 Diabetes 6 Array BioPharma and Amgen Partner in Type 2 Diabetes 7 Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2 Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3 Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4 Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5 The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2 Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2 Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3

[0] Array BioPharma and Amgen Partner in Type 2 Diabetes [0] Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation [0] The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 [0] Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering

... Inc. announced the availability of a 20-watt combined power ... seven high-power emitter outputs. The new combination provides an ... marking, defense, telecommunications and medical laser applications. , ,In ... the foundation of a modular fiber laser. It is ...

... Wisconsin Rapids, Wis. Renaissance Learning, a provider ... for educators, announced Saturday the appointment of Arthur ... education officer. , ,Stellar plans to lead ... information system that allows educators to monitor progress ...

... that I fear is about to burst. Months ago, venture ... the idea that there was money to be made by ... all, function on who you know. Those relationships could be ... to include the networks of everyone you know -- and ...

Other Biology Technology:I'm Linked In, Now What? 2 I'm Linked In, Now What? 3 I'm Linked In, Now What? 4

Alfalight Packages 20-Watt Combined Power Module Web-Based Learning Developed under new Chief Education Officer I'm Linked In, Now What?

(Date:12/15/2009)... economic toll on society. It is estimated that 100 ... U.S. waters and it,s likely that rip currents account for ... exists between rip current research and public understanding. Rip ... more importantly, most people do not know how to even ... goal of the Rip Current Symposium is to identify advancements ...

(Date:12/14/2009)... -- (Dec. 14, 2009) -- Researchers at Rice University ... single nanoparticle that can be tracked in real time ... tags them with a fluorescent dye and kills them ... first examples from a growing field called "theranostics" that ... diseases in a single procedure. , The research is ...

(Date:12/14/2009)... Engineering Society (BMES) have founded a new journal ... CVET is a forum for research on ... The first issue of the new quarterly journal will ... publications at Springer, Annals of Biomedical Engineering ... Cardiovascular Engineering and Technology will present a wide ...

[0] 1st International Rip Current Symposium [0] Tracking new cancer-killing particles with MRI [0] Biomedical Engineering Society's new journal to be published by Springer

... the American Dental Association Foundation (ADAF) and the ... developed a new method for layering two kinds ... that may lead to improved reconstruction or repair ... pastes of powdered calcium and a phosphate compound ...

... combine forces? , Individuals with chronic myeloid ... as imatinib (Gleevec), which targets the protein known to ... BCR-ABL mutants emerge that are resistant to the effects ... as dasatinib (SPRYCEL), which targets BCR-ABL in a different ...

... pinpoints the location of every atom in a 450-million-yeard-old ... create the molecules modern version, according to researchers from ... the University of Oregon. , Until now, scientists trying ... molecules necessary for life have worked backwards, making educated ...

Other Biology News:Layered approach may yield stronger, more successful bone implants 2 JCI table of contents: Aug. 16, 2007 2 JCI table of contents: Aug. 16, 2007 3 JCI table of contents: Aug. 16, 2007 4 JCI table of contents: Aug. 16, 2007 5 JCI table of contents: Aug. 16, 2007 6 JCI table of contents: Aug. 16, 2007 7 Structure of 450 million year old protein reveals evolution's steps 2

Layered approach may yield stronger, more successful bone implants JCI table of contents: Aug. 16, 2007 Structure of 450 million year old protein reveals evolution's steps

Recombinant Human Erythropoietin (Tissue Culture Grade)...

... MBP Coated Microplate, 96 ... Buffer, 5X, #20 Magnesium/ATP Cocktail, #20-11 ... LumiGLO™ Chemiluminescen LumiGLO™ Chemiluminescen ... Quality Assurance: Routinely ...

Collected from 8-12 week old New Zealand or Californian rabbits. Aseptically collected and processed to minimize hemolytic activity. Pricing: $60/unit for 1 - 10 units...

Donor Goat Serum...

Biology Products:

Human Erythropoietin, Unconjugated from R&D Systems Kinase Chemiluminescent Assay Kit from Upstate Normal Rabbit Serum from Equitech-Bio Donor Goat Serum from Lifeblood Medical, Inc.

Novavax Reports Second Quarter 2009 Financi...(phone at 1 (866) 206-5917 (U.S. or Canad...)